tiprankstipranks
Kodiak Sciences Inc (KOD)
NASDAQ:KOD
US Market
KOD
Kodiak Sciences
RESEARCH TOOLSreports

Kodiak Sciences (KOD) Stock News & Sentiment

447 Followers
Kodiak Sciences’ Zenkuda Shows Strong Phase 3 GLOW2 Results
Premium
Company Announcements
Kodiak Sciences’ Zenkuda Shows Strong Phase 3 GLOW2 Results
3d ago
8K
KOD
KOD Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
KOD Upcoming Earnings Report: What to Expect?
6d ago
KOD
Kodiak Sciences: GLOW2 Readout as Key Catalyst for Tarcocimab Upside and Broader Pipeline Optionality
Premium
Ratings
Kodiak Sciences: GLOW2 Readout as Key Catalyst for Tarcocimab Upside and Broader Pipeline Optionality
2M ago
KOD
Kodiak Sciences Raises Capital Through Completed Stock Offering
Premium
Company Announcements
Kodiak Sciences Raises Capital Through Completed Stock Offering
3M ago
8K
KOD
Kodiak Sciences’ Promising Outlook: Buy Rating Affirmed Amid Positive Drug Developments and Strategic Adjustments
Premium
Ratings
Kodiak Sciences’ Promising Outlook: Buy Rating Affirmed Amid Positive Drug Developments and Strategic Adjustments
4M ago
KOD
Kodiak Sciences: Promising Pipeline and Strategic Differentiation Drive Buy Rating
Premium
Ratings
Kodiak Sciences: Promising Pipeline and Strategic Differentiation Drive Buy Rating
5M ago
KOD
Kodiak Sciences Faces Financial Challenges Amid R&D Focus
Premium
Company Announcements
Kodiak Sciences Faces Financial Challenges Amid R&D Focus
5M ago
KOD
More KOD News >

KOD News on the Web

KOD Stock Soars on Promising Phase III Data for Eye Disease Candidate
Zacks
Neutral
Why Kodiak Sciences Stock Is Suddenly Surging
TipRanks News
Bullish
Analysts’ Top Healthcare Picks: ARS Pharmaceuticals (SPRY), Kodiak Sciences (KOD)
TipRanks News
Bullish
Kodiak Sciences price target raised to $80 from $50 at UBS
TipRanks News
Bullish
Kodiak Sciences’ Zenkuda Shows Strong Phase 3 GLOW2 Results
TipRanks News
Bullish
KOD Highlights GLOW2 Phase 3 Success: Zenkuda Shows 62.5% DRSS Improvement and 85% Risk Reduction in Diabetic Retinopathy
Market Chameleon
Neutral
Kodiak Sciences price target raised to $58 from $38 at H.C. Wainwright
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE) and Kodiak Sciences (KOD)
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
KOD
Sector Average
Media Buzz
This Week24 articles
Weekly Average6.25 articles
News Sentiment
This Week94%
Sector Average66%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is KOD’s Media Buzz Sentiment?
24 articles about KOD were published this week. In an average week, 6.25 articles are published.
    What is KOD’s weekly average amount of articles?
    In an average week, 6.25 articles about KOD are published.
      What is KOD’s News Sentiment?
      94% of articles about KOD were positive this week, compared to its sector average of 66%.
        Healthcare Stocks that are Trending in the News
        WXIBFWuxi Biologics (Cayman)
        KODKodiak Sciences
        SHTDYSinopharm Group Co
        640China Resources Pharmaceutical Group Ltd.
        RZLTRezolute
        Showing the stocks with the most bullish news sentiment over the past week